Abstract
Sclerotherapy is the term used to describe the process of injecting sclerosant into varicose veins to cause obliteration of its endothelium, thus resulting in closure of veins. Sclerotherapy aims to achieve endoluminal damage and cause vein wall fibrosis [1–5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McPheeters HO. Treatment of varicose veins; a twenty-five year reflection. Minn Med. 1956;39:271–5.
Sigg K, Zelikovski A. “Quick treatment”: a modified method of sclerotherapy of varicose veins. Vasa. 1975;4:73–8.
Sigg K. Treatment of varicose veins and their complications. Dermatologica. 1950;100:315–20.
Fegan WG, Fitzgerald DE, Beesley WH. A modern approach to the injection treatment of varicose veins and its applications in pregnant patients. Am Heart J. 1964;68:757–64.
Fegan WG. Continuous compression technique of injecting varicose veins. Lancet. 1963;2:109–12.
Tournay R. Indications for a single sclerosing therapy or diphasic combined surgery-sclerosing therapy in varicose veins. Zentralbl Phlebol. 1965;87:133–42.
Wallois P. Incidents and accidents in the sclerosing treatment of varicose veins and their prevention. Phlebologie. 1971;24:217.
Cabrera Garido JR, Cabrera Garcia Olmedo JR, Olmedo DG. Nuevo metododel de esclerosis en las varices tronculares. Patol Vasculares. 1995;4:55–73.
Cabrera J, Redondo P, Becerra A, Garrido C, Cabrera J Jr, García-Olmedo MA, et al. Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol. 2004;140:667–73.
Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M, et al. Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83.9). Dermatol Surg. 2004;30:687–93.
Breu FX, Guggenbichler S, Wollmann JC. European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37(suppl 71):1–29.
Breu FX, Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy, April 4–6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30:709–17.
Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27:58–60.
Bergan J. Sclerotherapy: a truly minimally invasive technique. Perspect Vasc Surg Endovasc Ther. 2008;20:70–2.
Perrin M, Gillet J-L. Management of recurrent varices at the popliteal fossa after surgical treatment. Phlebology. 2008;23(2):64–8.
Perrin MR, Guex JJ, Ruckley CV, et al. Recurrent varices after surgery (REVAS), a consensus document. Cardiovasc Surg. 2000;8(4):233–45.
Malgor RD, Labropoulos N. Pattern and types of non-saphenous vein reflux. Phlebology. 2013;28(Suppl 1):51–4.
Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg. 2011;42(1):107–14.
Paraskevas P. Successful ultrasound-guided foam sclerotherapy for vulval and leg varicosties secondary to ovarian vein reflux: a case study. Phlebology. 2011;26(1):29–31.
Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg. 2007;26:22–8.
Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy: etiology, prevention, and treatment. Dermatol Surg. 1995;21:19–29.
Guex JJ. Complications and side-effects of foam sclerotherapy. Phlebology. 2009;24:270–4.
Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins. Dermatol Surg. 2000;26:535–41.
Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008;358:1525–6.
Hobbs JT. The treatment of varicose veins: a random trial of injection- compression therapy versus surgery. Br J Surg. 1968;55:777–80.
Chant AD, Jones HO, Weddell JM. Varicose veins: a comparison of surgery and injection-compression sclerotherapy. Lancet. 1972;2:1188–91.
Kern P, Ramelet AA, Wütschert R, Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg. 2007;45:1212–6.
Goldman MP. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol. Dermatol Surg. 2002;28:52–5.
Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg. 2008;35:238–45.
Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev. 2006;18(4):CD001732.
Rigby KA, Palfreyman SJ, Beverley C, Michaels JA. Surgery versus sclerotherapy for the treatment of varicose veins. Cochrane Database Syst Rev. 2004;18(4):CD004980.
Luebke T, Brunkwall J. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cadiovasc Surg. 2008;49:213–33.
Wang JC, Li Y, Li GY, Xiao Y, Li WM, Ma Q, Liu JL, Lu SY. A comparison of concomitant tributary laser ablation and foam sclerotherapy in patients undergoing truncal endovenous laser ablation for lower limb varicose veins. J Vasc Interv Radiol. 2018;29(6):781–9. https://doi.org/10.1016/j.jvir.2018.01.774. [Epub ahead of print].
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Grover, T. (2018). Sclerotherapy for Varicose Veins. In: Khanna, A., Jindal, R. (eds) Venous Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-13-1108-6_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-1108-6_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1107-9
Online ISBN: 978-981-13-1108-6
eBook Packages: MedicineMedicine (R0)